Anti-resorptive drugs in Fibrous Dysplasia of bone: studies on the effects of a RANKL inhibitor and Zoledronic Acid in a murine model of the disease by radiography, histology

Awardee: Mara Riminucci

Institution: Sapienza University of Rome

Award Amount: $68,185

Funding Period: February 1, 2019 - January 31, 2020

Previous
Previous

Validation of pupil size as a biomarker for CDKL5 disorder: longitudinal assessment and relationship with disease severity

Next
Next

Small molecule modulators of telomerase as novel treatments for dyskeratosis congenita